Final Results from a Phase III Randomized Clinical Trial of Adjuvant Endocrine Therapy ± Chemotherapy in Women ≥ 70 Years Old with ER+ HER2- Breast Cancer and a High Genomic Grade Index: the Unicancer ASTER 70s Trial.